Edition:
United States

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

0.89USD
17 Aug 2018
Change (% chg)

$0.00 (+0.11%)
Prev Close
$0.88
Open
$0.90
Day's High
$0.90
Day's Low
$0.89
Volume
3,659
Avg. Vol
49,150
52-wk High
$1.34
52-wk Low
$0.78

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.03 0.10 0.00 0.00
Quarter Ending Dec-18 4 0.04 0.15 0.00 0.00
Year Ending Dec-18 4 0.06 0.25 0.00 2.55
Year Ending Dec-19 4 16.20 63.60 0.00 26.77
Earnings (per share)
Quarter Ending Sep-18 4 -0.06 -0.05 -0.07 -0.06
Quarter Ending Dec-18 4 -0.06 -0.05 -0.08 -0.06
Year Ending Dec-18 4 -0.23 -0.21 -0.27 -0.02
Year Ending Dec-19 4 -0.15 0.14 -0.30 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta -- 0.78 0.84
Price to Sales (TTM) -- 126.22 5.98
Price to Book (MRQ) -- 13.00 3.69
Price to Tangible Book (MRQ) -- 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -- 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) -- 5.42 3.53
LT Debt to Equity (MRQ) -- 19.75 11.27
Total Debt to Equity (MRQ) -- 23.48 14.23
Interest Coverage (TTM) -- -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -189.34 15.82
Operating Margin (TTM) -- -673.76 3.86
Operating Margin - 5 Yr. Avg. -- -202.74 10.95
Pre-Tax Margin (TTM) -- -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -203.67 11.12
Net Profit Margin (TTM) -- -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -- -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,071,848 718,909,906
Net Income/Employee (TTM) -- -6,208,777 83,624,743
Receivable Turnover (TTM) -- 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) -- 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 1.88 10.04
Return on Assets - 5 Yr. Avg. -- 2.31 10.94
Return on Investment (TTM) -- 2.89 12.63
Return on Investment - 5 Yr. Avg. -- 1.68 14.14
Return on Equity (TTM) -- 1.65 14.82
Return on Equity - 5 Yr. Avg. -- -6.94 15.50
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.